Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05242 |
CRLF2/TSLPR Protein, Human, Recombinant (His)
CRL2,CRLF2Y,TSLPR,cytoki... |
Human | HEK293 Cells |
CRLF2/TSLPR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25.6 kDa and the accession number is D0E2W4. | |||
TMPY-05769 |
CRLF2/TSLPR Protein, Human, Recombinant (hFc)
CRLF2Y,cytokine receptor-like factor 2... |
Human | HEK293 Cells |
CRLF2/TSLPR Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 50.91 kDa and the accession number is D0E2W4. | |||
TMPK-01331 |
TSLPR Protein, Cynomolgus, Recombinant (His)
CRL2,CRLF2,IL-XR,CRL... |
Cynomolgus | HEK293 Cells |
Thymic stromal lymphopoietin (TSLP) is an interleukin-7 (IL-7) like cytokine, which plays an important role in the regulation of immune responses to allergens. TSLP binds to a heterodimeric receptor complex composed of the IL-7 receptor alpha chain (IL-7Ralpha) and the TSLP receptor (TSLPR, also known as CRLF2). | |||
TMPJ-00530 |
TSLPR Protein, Mouse, Recombinant (hFc)
CRLF2,CRL2 cytokine rece... |
Mouse | HEK293 Cells |
TSLPR Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 62-88 KDa and the accession number is AAH23788.1. | |||
TMPJ-00531 |
TSLPR Protein, Mouse, Recombinant (His)
Cytokine receptor-like 2,Thymic stromal-derived lym... |
Mouse | HEK293 Cells |
TSLPR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 35-40 KDa and the accession number is AAH23788.1. | |||
TMPY-04272 |
FcRH2/FCRL2 Protein, Human, Recombinant (His)
IFGP4,FCRH2,CD307b,SPAP1,SPAP1B,Fc receptor like |
Human | HEK293 Cells |
Fc receptor-like 2 (FCRL2) is highly expressed on B-cell chronic lymphocytic leukemia (B-CLL) cells and could possibly influence disease pathogenesis. FCRL2 has robust predictive value for determining IGHV gene mutation status and clinical progression and thus may further improve prognostic definition in CLL (B-cell chronic lymphocytic leukemia). | |||
TMPH-01650 |
PRAME Protein, Human, Recombinant (E. coli, His)
|
Human | E. coli |
Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex, which mediates ubiquitination of target proteins, leading to their degradation. The CRL2(PRAME) complex mediates ubiquitination and degradation of truncated MSRB1/SEPX1 selenoproteins produced by failed UGA/Sec decoding. In the nucleus, the CRL2(PRAME) complex is recruited to epigenetically and transcriptionally active promoter regions bound by nuclear transcription factor Y (NFY) and probably plays a role... |